This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kamangar, F. Articles by Anderson, W. F. Search for Related Content PubMed PubMed Citation Articles by Kamangar, F. Articles by Anderson, W. F. Related Articles Related Correspondence

Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World

Farin Kamangar, Graça M. Dores, William F. Anderson

From the Nutritional Epidemiology and Biostatistics Branches, Division of Cancer Epidemiology and Genetics; Office of Preventive Oncology, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services.

Address reprint requests to William F. Anderson, MD, MPH, Descriptive Studies Section, Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Executive Plaza South, Room 8036, 6120 Executive Blvd, Rockville, MD 20852-7244; e-mail: wanderso{at}mail.nih.gov

Efforts to reduce global cancer disparities begin with an understanding of geographic patterns in cancer incidence, mortality, and prevalence. Using the GLOBOCAN (2002) and Cancer Incidence in Five Continents databases, we describe overall cancer incidence, mortality, and prevalence, age-adjusted temporal trends, and age-specific incidence patterns in selected geographic regions of the world. For the eight most common malignancies—cancers of lung, breast, colon and rectum, stomach, prostate, liver, cervix, and esophagus—the most important risk factors, cancer prevention and control measures are briefly reviewed.

In 2002, an estimated 11 million new cancer cases and 7 million cancer deaths were reported worldwide; nearly 25 million persons were living with cancer. Among the eight most common cancers, global disparities in cancer incidence, mortality, and prevalence are evident, likely due to complex interactions of nonmodifiable (ie, genetic susceptibility and aging) and modifiable risk factors (ie, tobacco, infectious agents, diet, and physical activity). Indeed, when risk factors among populations are intertwined with differences in individual behaviors, cultural beliefs and practices, socioeconomic conditions, and health care systems, global cancer disparities are inevitable. For the eight most common cancers, priorities for reducing cancer disparities are discussed.

Supported in part by the Intramural Research Program of the National Institutes of Health/National Cancer Institute (Bethesda, MD).

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

Related Correspondence

• Hypofractionated Radiation Therapy in Breast Cancer: A Revolutionary Breakthrough or a Long Way to Go?
  Anusheel Munshi and Ashwini Budrukkar
  JCO 2007 25: 458-459 [Full Text]

This article has been cited by other articles:

				K. Dahl, M. Karlsson, P. Marits, A. Hoffstedt, O. Winqvist, and M. Thorn Metinel Node--The First Lymph Node Draining a Metastasis--Contains Tumor-Reactive Lymphocytes Ann. Surg. Oncol., May 1, 2008; 15(5): 1454 - 1463. [Abstract] [Full Text] [PDF]

				F. M. Speetjens, P. J.K. Kuppen, M. H. Sandel, A. G. Menon, D. Burg, C. J.H. van de Velde, R. A.E.M. Tollenaar, H. J.G.M. de Bont, and J. F. Nagelkerke Disrupted Expression of CXCL5 in Colorectal Cancer Is Associated with Rapid Tumor Formation in Rats and Poor Prognosis in Patients Clin. Cancer Res., April 15, 2008; 14(8): 2276 - 2284. [Abstract] [Full Text] [PDF]

				K. Outterson and A. S. Kesselheim Market-Based Licensing For HPV Vaccines In Developing Countries Health Aff., January 1, 2008; 27(1): 130 - 139. [Abstract] [Full Text] [PDF]

				N. Choong and E. Vokes Expanding Role of the Medical Oncologist in the Management of Head and Neck Cancer CA Cancer J Clin, January 1, 2008; 58(1): 32 - 53. [Abstract] [Full Text] [PDF]

				E. S. Thomas, H. L. Gomez, R. K. Li, H.-C. Chung, L. E. Fein, V. F. Chan, J. Jassem, X. B. Pivot, J. V. Klimovsky, F. H. de Mendoza, et al. Ixabepilone Plus Capecitabine for Metastatic Breast Cancer Progressing After Anthracycline and Taxane Treatment J. Clin. Oncol., November 20, 2007; 25(33): 5210 - 5217. [Abstract] [Full Text] [PDF]

				D. Cunningham and Y. J. Chua East Meets West in the Treatment of Gastric Cancer N. Engl. J. Med., November 1, 2007; 357(18): 1863 - 1865. [Full Text] [PDF]

				B. Li, P. Y. Cheung, X. Wang, S. W. Tsao, M. T. Ling, Y. C. Wong, and A. L.M. Cheung Id-1 activation of PI3K/Akt/NF{kappa}B signaling pathway and its significance in promoting survival of esophageal cancer cells Carcinogenesis, November 1, 2007; 28(11): 2313 - 2320. [Abstract] [Full Text] [PDF]

				S. Lorenzen, M. Hentrich, C. Haberl, V. Heinemann, T. Schuster, T. Seroneit, N. Roethling, C. Peschel, and F. Lordick Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial Ann. Onc., October 1, 2007; 18(10): 1673 - 1679. [Abstract] [Full Text] [PDF]

				C. M. Greiser, E. M. Greiser, and M. Doren Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis Hum. Reprod. Update, September 1, 2007; 13(5): 453 - 463. [Abstract] [Full Text] [PDF]

				C.-X. Qu, F. Kamangar, J.-H. Fan, B. Yu, X.-D. Sun, P. R. Taylor, B. E. Chen, C. C. Abnet, Y.-L. Qiao, S. D. Mark, et al. Chemoprevention of Primary Liver Cancer: A Randomized, Double-Blind Trial in Linxian, China J Natl Cancer Inst, August 15, 2007; 99(16): 1240 - 1247. [Abstract] [Full Text] [PDF]

				M. V. Karamouzis, J. R. Grandis, and A. Argiris Therapies Directed Against Epidermal Growth Factor Receptor in Aerodigestive Carcinomas JAMA, July 4, 2007; 298(1): 70 - 82. [Abstract] [Full Text] [PDF]

				R. K. Matsuno, W. F. Anderson, S. Yamamoto, H. Tsukuma, R. M. Pfeiffer, K. Kobayashi, S. S. Devesa, and P. H. Levine Early- and Late-Onset Breast Cancer Types Among Women in the United States and Japan Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1437 - 1442. [Abstract] [Full Text] [PDF]

				A. A. Khorana, S. A. Ahrendt, C. K. Ryan, C. W. Francis, R. H. Hruban, Y. C. Hu, G. Hostetter, J. Harvey, and M. B. Taubman Tissue Factor Expression, Angiogenesis, and Thrombosis in Pancreatic Cancer Clin. Cancer Res., May 15, 2007; 13(10): 2870 - 2875. [Abstract] [Full Text] [PDF]

				J. E. Povey, F. Darakhshan, K. Robertson, Y. Bisset, M. Mekky, J. Rees, V. Doherty, G. Kavanagh, N. Anderson, H. Campbell, et al. DNA repair gene polymorphisms and genetic predisposition to cutaneous melanoma Carcinogenesis, May 1, 2007; 28(5): 1087 - 1093. [Abstract] [Full Text] [PDF]

				F. Kamangar, Y.-T. Gao, X.-O. Shu, K. Kahkeshani, B.-T. Ji, G. Yang, H.-L. Li, N. Rothman, W.-H. Chow, and W. Zheng Ginseng Intake and Gastric Cancer Risk in the Shanghai Women's Health Study Cohort Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 629 - 630. [Full Text] [PDF]

				A. Munshi and A. Budrukkar Hypofractionated Radiation Therapy in Breast Cancer: A Revolutionary Breakthrough or a Long Way to Go? J. Clin. Oncol., February 1, 2007; 25(4): 458 - 459. [Full Text] [PDF]

				L. E. Mechanic, E. D. Bowman, J. A. Welsh, M. A. Khan, N. Hagiwara, L. Enewold, P. G. Shields, L. Burdette, S. Chanock, and C. C. Harris Common Genetic Variation in TP53 Is Associated with Lung Cancer Risk and Prognosis in African Americans and Somatic Mutations in Lung Tumors Cancer Epidemiol. Biomarkers Prev., February 1, 2007; 16(2): 214 - 222. [Abstract] [Full Text] [PDF]

				M. A. Shah, R. K. Ramanathan, D. H. Ilson, A. Levnor, D. D'Adamo, E. O'Reilly, A. Tse, R. Trocola, L. Schwartz, M. Capanu, et al. Multicenter Phase II Study of Irinotecan, Cisplatin, and Bevacizumab in Patients With Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma J. Clin. Oncol., November 20, 2006; 24(33): 5201 - 5206. [Abstract] [Full Text] [PDF]

				E. Grunfeld Looking Beyond Survival: How Are We Looking at Survivorship? J. Clin. Oncol., November 10, 2006; 24(32): 5166 - 5169. [Abstract] [Full Text] [PDF]

				O. I. Olopade, G. Schwartsmann, N. Saijo, and C. R. Thomas Jr Disparities in Cancer Care: A Worldwide Perspective and Roadmap for Change J. Clin. Oncol., May 10, 2006; 24(14): 2135 - 2136. [Full Text] [PDF]